Rong Liang
Guangzhou University of Chinese Medicine(CN)Bureau of Land Management(US)Ministry of Education of the People's Republic of China(CN)Buck Institute for Research on Aging(US)Jinan University(CN)Guangxi Medical University(CN)Guangdong Medical College(CN)Peking University(CN)Guilin University of Aerospace Technology(CN)Guilin University of Technology(CN)Soochow University(CN)Guangxi Science and Technology Department(CN)Peking University People's Hospital(CN)First Affiliated Hospital of Soochow University(CN)Tumor Hospital of Guangxi Medical University(CN)Guilin University of Electronic Technology(CN)Jiangxi University of Finance and Economics(CN)China Southern Power Grid (China)(CN)South China University of Technology(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cancer-related molecular mechanisms research, RNA modifications and cancer, Traditional Chinese Medicine Studies
Most-Cited Works
- → Emerging therapies for glioblastoma: current state and future directions(2022)493 cited
- → Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma(2019)246 cited
- → Comparison of predicted and actual consequences of missense mutations(2015)231 cited
- → Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis(2018)164 cited
- → <p>Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer</p>(2020)147 cited
- Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model.(2001)
- → siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication(2005)